Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry

被引:40
作者
Wu, Eveline Y. [1 ]
Li, Suzanne C. [2 ]
Torok, Kathryn S. [3 ]
Virkud, Yamini V. [4 ]
Fuhlbrigge, Robert C. [5 ]
Rabinovich, C. Egla [6 ]
机构
[1] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
[2] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[3] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA
[4] Massachusetts Gen Hosp Children, Boston, MA USA
[5] Univ Colorado Denver, Aurora, CO USA
[6] Duke Univ, Med Ctr, Durham, NC USA
关键词
CARRA; juvenile localized scleroderma; morphea; CHILDREN; MORPHEA; ADULTS; FEATURES; DELAY; CARE;
D O I
10.1002/acr2.1019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Localized scleroderma (LS) is a chronic inflammatory and fibrosing skin disorder. We present baseline data on the juvenile LS (jLS) cohort from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry, a multicenter observational registry of pediatric rheumatologic disorders. Methods. This is a cross-sectional analysis of children with jLS enrolled in the CARRA Legacy Registry between May 2010 and April 2014. Descriptive statistics were used for demographic, clinical, and laboratory features. Data analysis included two-sample t test, chi(2) test, Fisher's exact test, linear/logistic regression, and analysis of variance. Results. Of 381 children with jLS, 76% were female and 80% Caucasian. Mean onset age was 8.2 years, with 17% having a 2-year or greater delay to first pediatric rheumatology (PRH) visit. Linear scleroderma was the most common subtype (54%). Antinuclear antibody (ANA) positivity was associated with joint contracture (P = 0.04), muscle atrophy (P = 0.014), and extremity shortening (P = 0.007). Elevated aldolase was associated with joint contracture (P = 0.008) and elevated creatine kinase (CK) with muscle atrophy (P = 0.028) and extremity shortening (P = 0.016). Children with functional limitation (27%) had earlier first PRH visit compared with those without (P = 0.01). Poorer function correlated with muscle atrophy, joint contracture, and extremity shortening (P < 0.001). Methotrexate (97%) and corticosteroids (68%) were the most common medications used. Conclusion. Children with jLS without joint limitation are referred later, highlighting the insidious onset and need for educating referring providers. Poorer function correlated with muscle atrophy, joint contracture, and limb shortening. ANA positivity and elevated CK or aldolase were associated with muscle atrophy, joint contracture, and/or limb shortening, suggesting predictors of muscle involvement.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 19 条
  • [1] Predictors of Longitudinal Quality of Life in Juvenile Localized Scleroderma
    Ardalan, Kaveh
    Zigler, Christina K.
    Torok, Kathryn S.
    [J]. ARTHRITIS CARE & RESEARCH, 2017, 69 (07) : 1082 - 1087
  • [2] Development of minimum standards of care for juvenile localized scleroderma
    Constantin, Tamas
    Foeldvari, Ivan
    Pain, Clare E.
    Palinkas, Annamaria
    Hoeger, Peter
    Moll, Monika
    Nemkova, Dana
    Weibel, Lisa
    Laczkovszki, Melinda
    Clements, Philip
    Torok, Kathryn S.
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2018, 177 (07) : 961 - 977
  • [3] Morphea in Adults and Children Cohort III Nested Case-Control Study-The Clinical Significance of Autoantibodies in Morphea
    Dharamsi, Jennifer Warner
    Victor, Sandra
    Aguwa, Nancy
    Ahn, Chul
    Arnett, Frank
    Mayes, Maureen D.
    Jacobe, Heidi
    [J]. JAMA DERMATOLOGY, 2013, 149 (10) : 1159 - 1165
  • [4] New Developments in Juvenile Systemic and Localized Scleroderma
    Foeldvari, Ivan
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2013, 39 (04) : 905 - +
  • [5] Development of the PROMISA® pediatric global health (PGH-7) measure
    Forrest, Christopher B.
    Bevans, Katherine B.
    Pratiwadi, Ramya
    Moon, JeanHee
    Teneralli, Rachel E.
    Minton, Jo M.
    Tucker, Carole A.
    [J]. QUALITY OF LIFE RESEARCH, 2014, 23 (04) : 1221 - 1231
  • [6] Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK
    Hawley, Daniel P.
    Baildam, Eileen M.
    Amin, Tania S.
    Cruikshank, Mary K.
    Davidson, Joyce E.
    Dixon, Jennifer
    Martin, Neil S.
    Ohlsson, Victoria
    Pilkington, Clarissa
    Rangaraj, Satyapal
    Riley, Philip
    Sundaramoorthy, Chitra
    Walsh, Jo
    Foster, Helen E.
    [J]. RHEUMATOLOGY, 2012, 51 (07) : 1235 - 1239
  • [7] Clinical features of childhood localized scleroderma in an incidence cohort
    Herrick, Ariane L.
    Ennis, Holly
    Bhushan, Monica
    Silman, Alan J.
    Baildam, Eileen M.
    [J]. RHEUMATOLOGY, 2011, 50 (10) : 1865 - 1868
  • [8] THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY 1991 REVISED CRITERIA FOR THE CLASSIFICATION OF GLOBAL FUNCTIONAL STATUS IN RHEUMATOID-ARTHRITIS
    HOCHBERG, MC
    CHANG, RW
    DWOSH, I
    LINDSEY, S
    PINCUS, T
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (05): : 498 - 502
  • [9] Morphea in adults and children cohort II: Patients with morphea experience delay in diagnosis and large variation in treatment
    Johnson, Weilan
    Jacobe, Heidi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (05) : 881 - 889
  • [10] Localized scleroderma
    Laxer, Ronald M.
    Zulian, Francesco
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (06) : 606 - 613